mighty maggots and bairnsdale ulcer town talk 21st nov 2013
DESCRIPTION
This is an example of one of the many community outreach talks I have been asked to deliver as the result of my pozible.com/mightymaggots crowdfunding campaign. It is hoped one day that Deakin will have KPIs for this kind of engagement, so I can get professional recognition on top of the warm fuzzy feelings I get from Outreach!TRANSCRIPT
CRICOS Provider Code: 00113B
BAIRNSDALE ULCER & MIGHTY MAGGOTS
Dr Melanie Thomson – Deakin Medical School, Waurn Ponds
CRICOS Provider Code: 00113B
WHAT IS MAGGOT DEBRIDEMENT THERAPY?
CRICOS Provider Code: 00113B
WHAT IS MDT? • Maggot therapy is also known as maggot
debridement therapy (MDT), larval therapy, larva therapy, larvae therapy, biodebridement or biosurgery.
• It is a type of biotherapy involving the introduction of live, disinfected maggots (fly larvae) into the non-healing skin and soft tissue wound(s) of a human for necrotic tissue debridement and disinfection
CRICOS Provider Code: 00113B
LIFE CYCLE OF THE FLY
CRICOS Provider Code: 00113B
HISTORY OF MAGGOT DEBRIDEMENT THERAPY
CRICOS Provider Code: 00113B
HISTORY OF MDT • Reports of the use of maggots for wound
healing by Maya Native Americans and Koorie tribes in Australia
• Military physicians have observed that soldiers whose wounds had become colonized with maggots experienced significantly less morbidity and mortality
• MDT Used extensively until the widespread use of penicillin rendered larval therapy obsolete
CRICOS Provider Code: 00113B
HISTORY OF MDT
CRICOS Provider Code: 00113B
IS MDT OBSOLETE IN 21ST CENTURY MEDICINE?
CRICOS Provider Code: 00113B
CRICOS Provider Code: 00113B
CURRENT CLINICAL USES FOR MDT
CRICOS Provider Code: 00113B
HOW DOES MAGGOT THERAPY WORK?
• The maggots debride the necrotic tissue, while disinfecting the wound
• They also change the wound environment to one that encourages new cell growth including granulation tissue development and fibroblast formation.
• The healthy tissue surrounding and underneath the wound remains untouched during larval therapy.
CRICOS Provider Code: 00113B
WHAT TYPE OF WOUNDS CAN BE TREATED?
Wounds that can be debrided include: Most non-healing necrotic skin and soft tissue wounds ie: • pressure ulcers, • venous stasis ulcers, • foot ulcers • non-healing traumatic or post surgical wounds • M. ulcerans ???
CRICOS Provider Code: 00113B
MDT FAQS “Can the maggots damage healthy tissue?” No, maggots will consume only dead tissue and
wound debris. “Will the maggots develop into flies within the
wound?” No, maggots will leave the wound to pupate,
however the maggots are removed through normal wound management.
CRICOS Provider Code: 00113B
MDT FAQS “Aren’t maggots dirty?” No, the maggots are disinfected and actually
destroy bacteria. “Will I be able to feel them & is it going to hurt?” It is uncommon for patients to experience any side
effects. “What happens if the maggots escape?” Nothing, maggots are harmless and easily destroyed. The restrictive dressings keep them at the wound site.
CRICOS Provider Code: 00113B
WOUND DRESSING WITH MDT How many maggots do I use? The normal rate of application is 5-8 maggots/cm2
of wound surface area. How long are the maggots left on the wound? The maggots can be left on the wound site for 48-
72hours. Mature maggots will try to escape from the wound but the dressings should prevent this.
Outer dressings changed every 24 hours, as liquefied tissue soaks through bandages
CRICOS Provider Code: 00113B
THE BAIRNSDALE ULCER – WHAT IS IT?
CRICOS Provider Code: 00113B
M. ULCERANS • Mycobacterium ulcerans causes a necrotising
infection of skin and subcutaneous tissue • After tuberculosis and leprosy, it is the third
most common mycobacterial infection worldwide among healthy individuals
• Human cases HERE in Victoria’s Bellarine Peninsula were first reported in 1998, and this is now recognised as an endemic area with the highest burden of disease in Australia
CRICOS Provider Code: 00113B
THE BURULI ULCER • West Africa, Benin, Côte d’Ivoire and Ghana
report most cases with Côte d’Ivoire reporting almost half of the global cases
CRICOS Provider Code: 00113B
M. ULCERANS • Studies of treatments have found that the
combination of antibiotic therapy and surgical debridement of diseased tissue is the most successful, although full recovery from a lesion caused by BU may take many months
CRICOS Provider Code: 00113B
FUTURE OF M. ULCERANS RESEARCH IN GEELONG
CRICOS Provider Code: 00113B
MU RESEARCH • Clinical Epidemiology – Dan O’Brien and Eugene Athan
at Barwon Health • Maggot (Larval) Therapy & Transmission studies using
passive flying insect vectors, Dr Michelle Harvey, Deakin LES (GCF grant 34K June 2013 + 9.9K Pozible donors)
• Transmission studies using marine ecosystem model – zebrafish, larval insects, Prof Alister Ward and Dr Mel Thomson (QPLCE grant $3K June 2013)
• Comparative Genetic Studies, Dr James Wynne, CSIRO AAHL
• GIS studies to look at Environmental Factors
CRICOS Provider Code: 00113B
CAN MDT TREAT THE BAIRNSDALE ULCER?
CRICOS Provider Code: 00113B
CLINICAL TRAIL OF MDT • Proposed feasibility study of the efficacy study
of MDT vs manual surgical debridement in MU • In at Barwon Health HREC at the moment • Will we get any recruits??? Rare disease,
increased community awareness……. • Novel Crowd Funding and Outreach approach to
sourcing the funds for the project at: www.pozible.com/mightymaggots @MightyMaggots on Twitter ‘Mighty Maggots at Deakin’ on Facebook
CRICOS Provider Code: 00113B
MAGGOT ART AND RACING! http://www.youtube.com/watch?v=H1WJZiflxi8
https://www.facebook.com/photo.php?v=10151412579891793
CRICOS Provider Code: 00113B
OUR MAGGOTS AND BUG IN CANBERRA!
CRICOS Provider Code: 00113B
ACKNOWLEDGEMENTS Barwon Health ID and Plastics teams: • Eugene Athan, Dan O’Brien & Anthony McDonald Deakin University: • Dr Michelle Harvey, LES
SPONSORS: 129 individuals @pozible.com +